Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-22

Clinical Trial Update: Evaluation of Erythropoietin on Alveolar Ridge Preservation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update shows Ain Shams University is recruiting for a study evaluating erythropoietin to preserve the alveolar ridge in patients with a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Erythropoietin (erythropoietin)

Snippet

Sponsor: Ain Shams University | Conditions: Alveolar Bone Loss | Phase 4 | Status: RECRUITING